Cargando…

Framework for Solid-Organ Transplantation During COVID-19 Pandemic in Europe

INTRODUCTION: Since the effect of the COVID-19 pandemic on solid-organ transplantation (SOT) is unclear, an online survey on the specific framework of leading European transplant centers (n=155) in 31 European countries was conducted between April 24 and May 15, 2020. METHODS: A questionnaire was de...

Descripción completa

Detalles Bibliográficos
Autores principales: Kniepeiss, Daniela, Jantscher, Lydia, Al-Sharafy, Shahdy, Sendlhofer, Gerald, Schemmer, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187091/
https://www.ncbi.nlm.nih.gov/pubmed/34113196
http://dx.doi.org/10.2147/RMHP.S286721
_version_ 1783705075162546176
author Kniepeiss, Daniela
Jantscher, Lydia
Al-Sharafy, Shahdy
Sendlhofer, Gerald
Schemmer, Peter
author_facet Kniepeiss, Daniela
Jantscher, Lydia
Al-Sharafy, Shahdy
Sendlhofer, Gerald
Schemmer, Peter
author_sort Kniepeiss, Daniela
collection PubMed
description INTRODUCTION: Since the effect of the COVID-19 pandemic on solid-organ transplantation (SOT) is unclear, an online survey on the specific framework of leading European transplant centers (n=155) in 31 European countries was conducted between April 24 and May 15, 2020. METHODS: A questionnaire was designed to collect information on restrictions on SOT, protective measures,(non)governmental information policies, and individual opinions on how to deal with SOT during COVID-19. RESULTS: The response rate was 37.4% (58 of 155). Overall, 84.5% reported an effect of COVID-19 on SOT in Europe. In 49% of these, limited capacity was mentioned, and in 51% the reason for restricted resources was strategic preparedness. As a result, SOT was totally or partially suspended for several weeks. In sum, 93.1% of centers implemented protective measures against COVID-19. Nongovernmental information policies were felt to be adequate in 90%. Continuation of transplant activities was desired by 97% of centers. CONCLUSION: The results of this survey suggested a need for more ICU capacity during COVID-19, in order to guarantee adequate and timely treatment of other patient cohorts in surveyed countries.
format Online
Article
Text
id pubmed-8187091
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-81870912021-06-09 Framework for Solid-Organ Transplantation During COVID-19 Pandemic in Europe Kniepeiss, Daniela Jantscher, Lydia Al-Sharafy, Shahdy Sendlhofer, Gerald Schemmer, Peter Risk Manag Healthc Policy Original Research INTRODUCTION: Since the effect of the COVID-19 pandemic on solid-organ transplantation (SOT) is unclear, an online survey on the specific framework of leading European transplant centers (n=155) in 31 European countries was conducted between April 24 and May 15, 2020. METHODS: A questionnaire was designed to collect information on restrictions on SOT, protective measures,(non)governmental information policies, and individual opinions on how to deal with SOT during COVID-19. RESULTS: The response rate was 37.4% (58 of 155). Overall, 84.5% reported an effect of COVID-19 on SOT in Europe. In 49% of these, limited capacity was mentioned, and in 51% the reason for restricted resources was strategic preparedness. As a result, SOT was totally or partially suspended for several weeks. In sum, 93.1% of centers implemented protective measures against COVID-19. Nongovernmental information policies were felt to be adequate in 90%. Continuation of transplant activities was desired by 97% of centers. CONCLUSION: The results of this survey suggested a need for more ICU capacity during COVID-19, in order to guarantee adequate and timely treatment of other patient cohorts in surveyed countries. Dove 2021-06-04 /pmc/articles/PMC8187091/ /pubmed/34113196 http://dx.doi.org/10.2147/RMHP.S286721 Text en © 2021 Kniepeiss et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Kniepeiss, Daniela
Jantscher, Lydia
Al-Sharafy, Shahdy
Sendlhofer, Gerald
Schemmer, Peter
Framework for Solid-Organ Transplantation During COVID-19 Pandemic in Europe
title Framework for Solid-Organ Transplantation During COVID-19 Pandemic in Europe
title_full Framework for Solid-Organ Transplantation During COVID-19 Pandemic in Europe
title_fullStr Framework for Solid-Organ Transplantation During COVID-19 Pandemic in Europe
title_full_unstemmed Framework for Solid-Organ Transplantation During COVID-19 Pandemic in Europe
title_short Framework for Solid-Organ Transplantation During COVID-19 Pandemic in Europe
title_sort framework for solid-organ transplantation during covid-19 pandemic in europe
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187091/
https://www.ncbi.nlm.nih.gov/pubmed/34113196
http://dx.doi.org/10.2147/RMHP.S286721
work_keys_str_mv AT kniepeissdaniela frameworkforsolidorgantransplantationduringcovid19pandemicineurope
AT jantscherlydia frameworkforsolidorgantransplantationduringcovid19pandemicineurope
AT alsharafyshahdy frameworkforsolidorgantransplantationduringcovid19pandemicineurope
AT sendlhofergerald frameworkforsolidorgantransplantationduringcovid19pandemicineurope
AT schemmerpeter frameworkforsolidorgantransplantationduringcovid19pandemicineurope